Pharmafile Logo
Pharmafocus logo
Advanced Search

Valeant

Showing 15 posts of 90 posts found.

valeant_sign

US Congress Committee pressures Valeant to produce drug pricing documents

March 11, 2016
Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …

News
valeant

Valeant ends controversial litigation with R&O Pharmacy

March 10, 2016
Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal

Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …

News
deb_jorn

Valeant company group chairman and executive vice president resigns

March 3, 2016
Medical Communications, Sales and Marketing Valeant, appointed, resignation

In an already troubled week for Valeant Pharmaceuticals, the company has now announced that its group chairman and executive vice …

Appointment
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

Clinton steps up attacks on Valeant in latest campaign advert

March 2, 2016
Research and Development, Sales and Marketing Hilary Clinton, Valeant

This is not the first time the pharma industry has drawn the ire of the US presidential hopefuls, but Hilary …

News
valeant_logo_on_board

Valeant shares slide on SEC investigation announcement

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation

Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …

News
howard_schiller_valeant

Valeant likely to restate financial results after Philidore review

February 23, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Howard Schiller, Philidore, Valeant

Valeant says it is likely to restate its financial results for the last two years, in the wake of the …

News
Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016
Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …

News
martin_shkreli_smaller_same

Martin Shkreli subpoenaed in US to testify over drug pricing

January 21, 2016
Medical Communications, Sales and Marketing Daraprim, Howard Schiller, Martin Shkreli, Valeant, turing

Former pharma chief exec Martin Shkreli has been issued with a subpoena by the US House of representatives, compelling him …

News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016
Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

Feature
howard_schiller_valeant

Valeant names interim CEO in Pearson’s absence

January 6, 2016
Medical Communications, Sales and Marketing Valeant

Valeant has named company director Howard Schiller as interim chief executive officer to serve while full-time boss Michael Pearson is …

Appointment
kelner_rob_070427

Valeant hires attorney and crisis management firm to handle bad US PR

December 17, 2015
Medical Communications, Sales and Marketing Robert Kelner, Valeant, Vianovo. Covington & Burling

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …

Appointment
Turing logo

Top five pharma controversies of 2015 (so far)

November 20, 2015
Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing

5. AstraZeneca forced to deny tax avoidance allegations

Feature
mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …

Appointment
valeant_logo

Valeant drops Philidor after prescription fraud row

October 30, 2015
Medical Communications, Sales and Marketing Valeant

Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …

News
valeant_logo_on_board

CEO prepares for day of reckoning over Valeant fraud allegations

October 26, 2015
Sales and Marketing J. Michael Pearson, Valeant

Troubled Valeant Pharmaceuticals last week announced strong third quarter revenues, reporting a 36% increase in revenues to $172 million, but …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025